Dak Gesundheit Tender

§ 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies Framework discount agreements on the drugs to be dispensed at the expense of the statutory health insurance companies close. With regard to the relevant statutory provisions on the award of public contracts, There is a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB by DAK-Gesundheit. For details from the bidder in Annex 2 to the contract naming medicines to the o. g. Active ingredient capsaicin, ATC N01BX04, DAK-Gesundheit intends to until new drug discount agreements come into force with as many interested pharmaceutical companies as possible companies to conclude drug discount agreements. A discount agreement i.R.d. admission model to the above The active substance comes into force for the first time on September 1st, 2022 and ends on August 31st, 2024. It ends regardless automatically when the exclusive contract comes into force.